Stock SPRO SPERO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Spero Therapeutics, Inc.

Equities

SPRO

US84833T1034

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
1.59 USD +1.27% Intraday chart for Spero Therapeutics, Inc. -3.05% +8.16%
May. 15 Earnings Flash (SPRO) SPERO THERAPEUTICS Reports Q1 Revenue $9.3M MT
Mar. 13 Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SPERO THERAPEUTICS, INC. Stock Spero Therapeutics, Inc.
 85.69M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
ARGENX SE Stock argenx SE
 21.96B -
BIONTECH SE Stock BioNTech SE
 21.87B -
GENMAB A/S Stock Genmab A/S
 19.21B
  1. Stock Market
  2. Equities
  3. SPRO Stock
  4. Charts Spero Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW